The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein
about
XPB induces C1D expression to counteract UV-induced apoptosis.BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability.Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitorsCaveolae-associated signalling in smooth muscle.Src kinases as targets for B cell acute lymphoblastic leukaemia therapy.Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity.The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation.BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia.Abnormalities of DNA repair mechanisms in common hematological malignancies.Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia.The Dbl homology domain of BCR is not a simple spacer in P210BCR-ABL of the Philadelphia chromosome.Protein kinase CKIIalpha interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells.Fibronectin type I repeat is a nonactivating ligand for EphA1 and inhibits ATF3-dependent angiogenesis.
P2860
Q33953792-EC3D9DD5-08F4-4664-BB33-93FFB0677A8AQ35022527-C5258DA1-E0FC-408A-9765-3BBE9D15540FQ35459748-A2319BFA-9BEB-4998-AEEE-253F03EA391EQ35815016-B9AB4F33-2D02-40F3-B268-D738B68227E4Q36150854-8BDF2FD6-40BD-4B9E-AFA1-F580044E71E2Q36398134-F00F06D4-5514-431C-AE33-AE5A98711EA0Q37148115-0BAF5D4E-75FD-4CDA-82F3-D027045AF3E4Q37178213-2E1AC67F-38A2-4275-B814-1BB99F27AB34Q37743173-4F0FBD93-06F2-4B0A-8D68-779FBF0F844AQ37857869-17621717-D480-4ECF-BDB1-45E61996833EQ38460343-5EED5D9C-B03C-440C-A585-52EFF9E54A66Q40786423-CA34563E-47E2-4B66-B69B-DE300D3EEA70Q44653664-8546FF71-E7EE-4000-A09B-08CFB05C6C36Q46727096-AE0990EE-D0EF-43A2-8647-69239C81D029
P2860
The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@ast
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@en
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@nl
type
label
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@ast
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@en
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@nl
prefLabel
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@ast
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@en
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@nl
P2860
P356
P1476
The BCR-ABL oncoprotein potent ...... ma pigmentosum group B protein
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.1.203
P407
P577
1999-01-01T00:00:00Z